LCTX insider buying & filings

LCTXLineage Cell Therapeutics, Inc.

NYSE American · Healthcare · $269.24M

$1.08

-2.70% · Jul 31

8 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Feb 13 · scanned 18m ago

Price · 1Y · dailyNo open-market activity in range

▸ hover a marker for the filing · drag to zoom

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$269.24M

Float

187.3M

75% public

Short % float

Pro

Price / profit

—

not yet profitable

Price / future profit

—

Price / sales

18.2

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Feb 13TAXSamuel George A. IIIGeneral Counsel and Secretarydirect2,502 @ $1.80$4.5K

Feb 13EXERCISESamuel George A. IIIGeneral Counsel and Secretarydirect6,075 sh—

Feb 13TAXCulley Brian MPresident and CEOdirect12,869 @ $1.80$23.2K

Feb 13EXERCISECulley Brian MPresident and CEOdirect31,250 sh—

Dec 19TAXSamuel George A. IIIGeneral Counsel and Secretarydirect65 @ $1.68$109.20

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice